Skip to main content
. 2023 Jul 7;13:1102936. doi: 10.3389/fonc.2023.1102936

Table 2.

Univariate cox regression analyses: outcome of poorly differentiated thyroid carcinoma recurrence-free survival and overall survival.

Variable Recurrence-free survival Overall survival
Hazard Ratio (95% CI) p-value Hazard Ratio (95% CI) p-value
Age at diagnosis (year) 1.039(1.017-1.061) <0.001 1.031(1.006-1.057) 0.014
Year of diagnosis (year) 0.962(0.894-1.036) 0.305 0.934(0.850-1.026) 0.153
Sex
Male 1 1
Female 0.875(0.525-1.458) 0.608 1.188(0.634-2.227) 0.591
Extrathyroidal extension
None 1 1
Yes 2.758(1.087-6.997) 0.033 3.662(1.100-12.187) 0.034
Multifocality
None 1 1
Yes 0.895(0.528-1.518) 0.681 1.235(0.657-2.319) 0.512
T stage (AJCC 8th)
T1 1 1
T2 1.599(0.577-4.427) 0.367 0.955(0.272-3.353) 0.943
T3 0.993(0.254-3.885) 0.992 0.933(0.219-3.974) 0.925
T4 3.601(1.583-8.191) 0.002 1.181(0.395-3.526) 0.766
N stage (AJCC 8th)
N0 1 1
N1 3.751(1.358-10.358) 0.011 2.230(0.657-7.566) 0.198
M stage (AJCC 8th)
M0 1 1
M1 2.197(1.277-3.780) 0.004 1.739(0.834-3.623) 0.140
Surgery
Biopsy or no surgery 1 1
Thyroidectomy only 0.302(0.161-0.567) <0.001 0.579(0.275-1.215) 0.148
Thyroidectomy +
lymph node dissection
0.493(0.262-0.928) 0.028 0.692(0.309-1.550) 0.371
Radiation
None or refused 1 1
Radioactive iodine 0.232(0.103-0.523) <0.001 0.487(0.186-1.273) 0.142
External beam radiotherapy 0.706(0.404-1.235) 0.223 0.845(0.437-1.633) 0.617
Chemotherapy
None or unknown 1 1
Yes 1.255(0.694-2.269) 0.452 0.670(0.333-1.345) 0.260
Associated thyroid cancer
Papillary only 1 1
Follicular only 0.767(0.301-1.954) 0.579 0.317(0.099-1.012) 0.052
Other 1.860(0.886-3.903) 0.101 1.076(0.460-2.516) 0.865
None 1.500(0.699-3.219) 0.298 0.820(0.624-2.076) 0.676